The International LAM Registry: A component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform

Michael Nurok, Ian Eslick, Carlos R R Carvalho, Ulrich Costabel, Jeanine D'Armiento, Allan R. Glanville, Sergio Harari, Elizabeth P. Henske, Yoshikazu Inoue, Simon R. Johnson, Jacques Lacronique, Romain Lazor, Joel Moss, Stephen J. Ruoss, Jay H Ryu, Kuniaki Seyama, Henrik Watz, Kai Feng Xu, Elizabeth L. Hohmann, Frank Moss

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: A relative inability to capture a sufficiently large patient population in any one geographic location has traditionally limited research into rare diseases. Methods and Results: Clinicians interested in the rare disease lymphangioleiomyomatosis (LAM) have worked with the LAM Treatment Alliance, the MIT Media Lab, and Clozure Associates to cooperate in the design of a state-of-the-art data coordination platform that can be used for clinical trials and other research focused on the global LAM patient population. This platform is a component of a set of web-based resources, including a patient self-report data portal, aimed at accelerating research in rare diseases in a rigorous fashion. Conclusions: Collaboration between clinicians, researchers, advocacy groups, and patients can create essential community resource infrastructure to accelerate rare disease research. The International LAM Registry is an example of such an effort.82

Original languageEnglish (US)
Pages (from-to)81-87
Number of pages7
JournalLymphatic Research and Biology
Volume8
Issue number1
DOIs
StatePublished - Mar 1 2010

Fingerprint

Lymphangioleiomyomatosis
Rare Diseases
Registries
Research Personnel
Research
Patient Advocacy
Geographic Locations
Self Report
Population
Clinical Trials

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The International LAM Registry : A component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform. / Nurok, Michael; Eslick, Ian; Carvalho, Carlos R R; Costabel, Ulrich; D'Armiento, Jeanine; Glanville, Allan R.; Harari, Sergio; Henske, Elizabeth P.; Inoue, Yoshikazu; Johnson, Simon R.; Lacronique, Jacques; Lazor, Romain; Moss, Joel; Ruoss, Stephen J.; Ryu, Jay H; Seyama, Kuniaki; Watz, Henrik; Xu, Kai Feng; Hohmann, Elizabeth L.; Moss, Frank.

In: Lymphatic Research and Biology, Vol. 8, No. 1, 01.03.2010, p. 81-87.

Research output: Contribution to journalArticle

Nurok, M, Eslick, I, Carvalho, CRR, Costabel, U, D'Armiento, J, Glanville, AR, Harari, S, Henske, EP, Inoue, Y, Johnson, SR, Lacronique, J, Lazor, R, Moss, J, Ruoss, SJ, Ryu, JH, Seyama, K, Watz, H, Xu, KF, Hohmann, EL & Moss, F 2010, 'The International LAM Registry: A component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform', Lymphatic Research and Biology, vol. 8, no. 1, pp. 81-87. https://doi.org/10.1089/lrb.2009.0028
Nurok, Michael ; Eslick, Ian ; Carvalho, Carlos R R ; Costabel, Ulrich ; D'Armiento, Jeanine ; Glanville, Allan R. ; Harari, Sergio ; Henske, Elizabeth P. ; Inoue, Yoshikazu ; Johnson, Simon R. ; Lacronique, Jacques ; Lazor, Romain ; Moss, Joel ; Ruoss, Stephen J. ; Ryu, Jay H ; Seyama, Kuniaki ; Watz, Henrik ; Xu, Kai Feng ; Hohmann, Elizabeth L. ; Moss, Frank. / The International LAM Registry : A component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform. In: Lymphatic Research and Biology. 2010 ; Vol. 8, No. 1. pp. 81-87.
@article{04e1df6742154ad89e19d9348ba62949,
title = "The International LAM Registry: A component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform",
abstract = "Background: A relative inability to capture a sufficiently large patient population in any one geographic location has traditionally limited research into rare diseases. Methods and Results: Clinicians interested in the rare disease lymphangioleiomyomatosis (LAM) have worked with the LAM Treatment Alliance, the MIT Media Lab, and Clozure Associates to cooperate in the design of a state-of-the-art data coordination platform that can be used for clinical trials and other research focused on the global LAM patient population. This platform is a component of a set of web-based resources, including a patient self-report data portal, aimed at accelerating research in rare diseases in a rigorous fashion. Conclusions: Collaboration between clinicians, researchers, advocacy groups, and patients can create essential community resource infrastructure to accelerate rare disease research. The International LAM Registry is an example of such an effort.82",
author = "Michael Nurok and Ian Eslick and Carvalho, {Carlos R R} and Ulrich Costabel and Jeanine D'Armiento and Glanville, {Allan R.} and Sergio Harari and Henske, {Elizabeth P.} and Yoshikazu Inoue and Johnson, {Simon R.} and Jacques Lacronique and Romain Lazor and Joel Moss and Ruoss, {Stephen J.} and Ryu, {Jay H} and Kuniaki Seyama and Henrik Watz and Xu, {Kai Feng} and Hohmann, {Elizabeth L.} and Frank Moss",
year = "2010",
month = "3",
day = "1",
doi = "10.1089/lrb.2009.0028",
language = "English (US)",
volume = "8",
pages = "81--87",
journal = "Lymphatic Research and Biology",
issn = "1539-6851",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - The International LAM Registry

T2 - A component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform

AU - Nurok, Michael

AU - Eslick, Ian

AU - Carvalho, Carlos R R

AU - Costabel, Ulrich

AU - D'Armiento, Jeanine

AU - Glanville, Allan R.

AU - Harari, Sergio

AU - Henske, Elizabeth P.

AU - Inoue, Yoshikazu

AU - Johnson, Simon R.

AU - Lacronique, Jacques

AU - Lazor, Romain

AU - Moss, Joel

AU - Ruoss, Stephen J.

AU - Ryu, Jay H

AU - Seyama, Kuniaki

AU - Watz, Henrik

AU - Xu, Kai Feng

AU - Hohmann, Elizabeth L.

AU - Moss, Frank

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Background: A relative inability to capture a sufficiently large patient population in any one geographic location has traditionally limited research into rare diseases. Methods and Results: Clinicians interested in the rare disease lymphangioleiomyomatosis (LAM) have worked with the LAM Treatment Alliance, the MIT Media Lab, and Clozure Associates to cooperate in the design of a state-of-the-art data coordination platform that can be used for clinical trials and other research focused on the global LAM patient population. This platform is a component of a set of web-based resources, including a patient self-report data portal, aimed at accelerating research in rare diseases in a rigorous fashion. Conclusions: Collaboration between clinicians, researchers, advocacy groups, and patients can create essential community resource infrastructure to accelerate rare disease research. The International LAM Registry is an example of such an effort.82

AB - Background: A relative inability to capture a sufficiently large patient population in any one geographic location has traditionally limited research into rare diseases. Methods and Results: Clinicians interested in the rare disease lymphangioleiomyomatosis (LAM) have worked with the LAM Treatment Alliance, the MIT Media Lab, and Clozure Associates to cooperate in the design of a state-of-the-art data coordination platform that can be used for clinical trials and other research focused on the global LAM patient population. This platform is a component of a set of web-based resources, including a patient self-report data portal, aimed at accelerating research in rare diseases in a rigorous fashion. Conclusions: Collaboration between clinicians, researchers, advocacy groups, and patients can create essential community resource infrastructure to accelerate rare disease research. The International LAM Registry is an example of such an effort.82

UR - http://www.scopus.com/inward/record.url?scp=77949823301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949823301&partnerID=8YFLogxK

U2 - 10.1089/lrb.2009.0028

DO - 10.1089/lrb.2009.0028

M3 - Article

C2 - 20235890

AN - SCOPUS:77949823301

VL - 8

SP - 81

EP - 87

JO - Lymphatic Research and Biology

JF - Lymphatic Research and Biology

SN - 1539-6851

IS - 1

ER -